Laboratory Grade Water Market

On 24 May 2023 Xylem completed its all-stock acquisition of Evoqua Water Technologies, a deal valued at about USD 7.5 billion, according to Xylem’s completion release filed with the SEC, which put the owner of Evoqua’s laboratory water systems and service deionisation network inside a group with USD 7.3 billion of pro forma revenue. With Veolia already owning ELGA LabWater and Merck KGaA running Milli-Q, the water that feeds analysers, chromatographs and cell culture media now sits mostly with large, service-led groups. Douglas Insights values the laboratory grade water market at USD 2.92 billion in 2025 and forecasts USD 5.15 billion by 2035, a compound growth rate of 5.83% a year. The receipt is adopters times spend: about 468,000 laboratories buying purified water systems, consumables, service or packaged water in 2025, at an average of USD 6,240 per laboratory per year. The volume leg adds 3.4% a year as biologics, clinical and Asian research laboratories open, and the spend leg adds 2.35% a year as labs move to Type I water, LC-MS grades and validated service. The study sits in Douglas Insights coverage of water and wastewater treatment and follows the Douglas Insights research methodology.

What counts as laboratory grade water here, from 18.2 megohm-cm polishers to bottled LC-MS water?

Laboratory grade water in this study is purified water that meets ASTM D1193, ISO 3696 or CLSI clinical laboratory reagent water grades and is used in laboratories, worth USD 2.92 billion in 2025. Type I ultrapure water reaches 18.2 megohm-cm at 25 degrees Celsius and feeds HPLC, LC-MS, ICP-MS and cell culture; Type II feeds buffers, media and analysers; Type III, usually reverse osmosis water, feeds glassware washers and autoclaves. Value reaches labs four ways: point-of-use purification systems, consumables, service, and packaged water, so the laboratory grade water market counts six segments: Cartridges, filters, UV lamps and RO membranes, Type I ultrapure water systems, Type II and Type III water systems, Packaged reagent-grade and LC-MS water, Service, validation and maintenance contracts, and Clinical analyser feed water systems.

It also splits value by grade into Type I ultrapure water, Type II pure water and Type III RO water, and by buyer into Pharmaceutical and biotechnology labs, Academic and government research labs, Clinical and hospital labs, and Industrial and environmental testing labs. Pharmaceutical production water loops, semiconductor ultrapure water plants and dialysis water are excluded; plant-scale treatment sits in the Industrial Water Treatment Chemicals Market report. Instruments that consume this water are sized in the Biotechnology Instruments Market and Osmometer Market reports.

What did Xylem’s 24 May 2023 purchase of Evoqua change for lab water service?

The purchase moved about 3.1% of 2025 laboratory grade water market revenue into Xylem, Douglas Insights estimates, and completed a shift in which three of the largest suppliers now belong to diversified water or life science groups. Evoqua brought laboratory purification systems and a network that swaps exhausted deionisation tanks on a schedule, a model close to a utility contract. Xylem described Evoqua as a leader in mission-critical water treatment solutions and services, and the combined company employs more than 22,000 people.

For laboratory grade water buyers the result is a service market. Veolia’s ELGA LabWater, Merck’s Milli-Q service teams and Xylem’s Evoqua routes compete to own the cartridge, sanitisation and validation calendar of each installed system, because a lab that signs a service plan rarely changes supplier before the unit retires.

Which rules from ASTM, ISO, CLSI and the pharmacopoeias fix laboratory grade water purity?

Four rulebooks define laboratory grade water, and Douglas Insights estimates about 71% of 2025 value is bought against a written grade. ASTM D1193 specifies Types I, II, III and IV and allows them to be made by alternate technologies provided the specifications are met, with tests for resistivity, pH, silica, sodium, chloride, total organic carbon, endotoxin and bacteria. ISO 3696 sets grades 1 to 3 for analytical work, and CLSI clinical laboratory reagent water guidance governs hospital analysers.

Pharmacopoeias set the fourth layer. USP chapters on conductivity and total organic carbon, and the European Medicines Agency’s guideline on the quality of water for pharmaceutical use, in effect since 1 February 2021, allow water for injections from reverse osmosis coupled with other techniques, not only distillation. That change moves membrane knowledge from plant rooms into QC laboratories, which must test the water they release against the same limits.

What price does laboratory grade water carry, from a tap-fed polisher to a 4-litre LC-MS bottle?

A laboratory spent an average USD 6,240 on laboratory grade water in 2025, and Douglas Insights expects about USD 7,870 by 2035. A Type I point-of-use polisher sells for USD 8,000 to USD 20,000 and a Type II or Type III system for USD 4,000 to USD 15,000, while a central building reverse osmosis loop costs USD 40,000 to USD 150,000. Cartridges cost USD 150 to USD 800 each, so a busy Type I system uses USD 1,200 to USD 2,500 of consumables a year, and a service plan adds USD 600 to USD 1,800. Packaged HPLC-grade water sells for USD 60 to USD 120 per 4-litre bottle and LC-MS grade for USD 40 to USD 90 per litre. In-house Type I water costs USD 0.50 to USD 2 per litre once a system is paid off, which is why labs using more than a few litres a day buy systems.

What drives laboratory grade water use in biologics, LC-MS and clinical chemistry?

Four forces add about 4.1 points a year to growth in laboratories buying laboratory grade water, while restraints remove about 0.7 points, leaving 3.4%. Biologics and pharmaceutical quality control come first. Every antibody, vaccine and cell therapy batch needs media, buffers and release tests made with Type I or Type II water, and Douglas Insights estimates Pharmaceutical and biotechnology labs spent USD 1.01 billion in 2025, adding about 1.4 points a year to laboratory growth as new QC suites open in Ireland, Singapore, India and the United States. A new biologics QC suite typically installs two to four Type I polishers and a Type II feed system on its first day.

Research budgets are the second driver. US research and development totalled USD 937 billion in 2023 and an estimated USD 993 billion in 2024, according to NCSES figures released on 27 February 2026. Douglas Insights estimates each USD 10 billion of added R&D equips about 1,100 more water-using laboratories, adding about 0.8 points a year to laboratory growth. Grant-funded cores buy water systems alongside sequencers, cytometers and mass spectrometers, and every new bench needs a supply of Type II water.

Trace analysis is the third driver and works mainly through spend. LC-MS and ICP-MS methods now read contaminants in parts per trillion, so labs replace Type II water with Type I polishers fitted with UV lamps and ultrafilters. Douglas Insights estimates Type I ultrapure water systems were worth USD 721 million in 2025 and grow 6.41% a year, adding about 1.1 points a year to spend per laboratory.

Asian laboratory build-out is the fourth driver. China, India and South Korea are opening contract research, biosimilar and hospital laboratories faster than any other region, and Douglas Insights estimates Asia Pacific adds about 1.9 points a year to global laboratory growth. Local brands compete on price, but multinational contract research firms in China and India specify the same Type I grades as their US and European sites, so spend per lab rises too. Service follows every installation: Service, validation and maintenance contracts grow 7.36% a year, the fastest segment, as the Xylem and Evoqua deal of 24 May 2023 shows how much suppliers value the recurring calendar.

What holds back spending per lab on laboratory grade water?

Academic budget swings are the first brake, removing about 0.4 points a year from growth in laboratories buying laboratory grade water. Academic and government research labs spent USD 698 million in 2025, and grant cuts or overhead caps pause both new systems and service renewals, so the slower case holds the laboratory leg at 2.1%.

Price pressure is the second restraint, removing about 0.3 points. Chinese system makers sell Type I units 30% to 45% below Western brands in tenders, and central reverse osmosis loops let one building feed dozens of labs through small polishers, cutting cartridge spend per lab by 15% to 25%. Longer-life cartridges with sensors that report remaining capacity also stretch change intervals.

Which laboratory grade water product carries the value: systems, cartridges, service or bottles?

Cartridges, filters, UV lamps and RO membranes carry the most laboratory grade water market value at 27.9% of 2025 revenue, USD 815 million, while service grows fastest at 7.36% a year.

Cartridges, filters, UV lamps and RO membranes are worth USD 815 million in 2025. Every installed system pulls two to four changes a year, so the segment grows 5.88% a year with the base.

Type I ultrapure water systems are worth USD 721 million in 2025, growing 6.41% a year as LC-MS and cell culture labs demand trace-free water.

Type II and Type III water systems are worth USD 491 million in 2025. Central loops share their output across many labs, holding growth to 4.12% a year, the slowest.

Packaged reagent-grade and LC-MS water is worth USD 386 million in 2025. Small labs and LC-MS users who need certified lots buy bottles, growing 5.47% a year.

Service, validation and maintenance contracts are worth USD 359 million in 2025 and grow fastest, at 7.36% a year to USD 731 million by 2035, because regulated labs need documented sanitisation and calibration.

Clinical analyser feed water systems are worth USD 149 million in 2025, growing 4.88% a year with hospital chemistry capacity.

How do ultrapure, pure and RO grades split laboratory grade water value?

Type I ultrapure water accounts for 46.2% of 2025 laboratory grade water market value, USD 1.35 billion, across systems, cartridges, service and bottles, Douglas Insights estimates. Type II pure water accounts for 31.5%, USD 920 million, the grade for buffers, media and most analysers. Type III RO water accounts for 22.3%, USD 651 million, feeding washers, autoclaves and the Type I polishers downstream.

Do drug makers, universities or hospital labs consume more laboratory grade water?

Pharmaceutical and biotechnology labs take 34.6% of 2025 laboratory grade water market value, USD 1.01 billion, because QC and process development run around the clock under written water specifications. Academic and government research labs take 23.9%, USD 698 million. Clinical and hospital labs take 21.8%, USD 637 million, where analysers consume water continuously. Industrial and environmental testing labs take 19.7%, USD 575 million, led by food, environmental and petrochemical testing.

Which region fills the most lab carboys, and what lifts Asia Pacific near 8% a year?

North America is the largest laboratory grade water region at USD 1.05 billion in 2025, 35.8% of the laboratory grade water market, and grows 4.93% a year to USD 1.69 billion by 2035. The United States hosts the largest biopharma QC base and the densest service networks, including Xylem’s Evoqua routes.

Asia Pacific is the fastest region at USD 780 million in 2025 and 7.97% a year to USD 1.68 billion by 2035, as China, India and South Korea open contract research, biosimilar and hospital laboratories and local brands widen access.

Europe spends USD 859 million and grows 4.46% a year to USD 1.33 billion, the slowest, because its lab base is mature and central loops are common. Latin America spends USD 134 million and grows 6.38% a year to USD 249 million, led by Brazil and Mexico. The Middle East and Africa is the wildcard at USD 102 million in 2025 and 6.87% a year to USD 199 million: Gulf hospital and vaccine projects could add labs quickly, but hard, saline feed water raises pretreatment costs.

Which companies purify laboratory grade water, and how far does Milli-Q lead?

Douglas Insights estimates Merck KGaA, through Milli-Q, holds about 21.4% of 2025 laboratory grade water market revenue and the top three suppliers about 42.8%.

Advantage in the laboratory grade water market rests on installed base and service reach, which is why Xylem paid for Evoqua’s routes on 24 May 2023.

How large could laboratory grade water be in 2035 if biologics capacity keeps expanding?

The base case takes the laboratory grade water market to USD 5.15 billion by 2035, inside a range of USD 4.05 billion to USD 6.34 billion. The slower case assumes research budgets stall and Asian price competition deepens, with legs of 2.1% and 1.2% for USD 4.05 billion. The faster case assumes biologics and Asian research capacity keep expanding and consolidated suppliers such as Xylem, Veolia and Merck lift service attach rates, with legs of 4.6% and 3.3% for USD 6.34 billion. Each 1-point change in the laboratory leg moves the 2035 figure by about USD 520 million. Published estimates run from about 4.9% to 8.1% a year; the Douglas Insights 5.83% sits in the lower half because production water loops are excluded.

Douglas Exclusive: the laboratory grade water cartridge-swap ledger

The laboratory grade water cartridge-swap ledger reads service and consumable records for 2,480 systems at 311 academic, pharmaceutical, clinical and industrial sites in 18 countries between 2023 and 2025, and records each system’s grade, feed water, litres produced, cartridge changes, UV lamp changes and service visits. It shows a median of 2.6 cartridge changes a year on Type I systems and 1.4 on Type II systems, and that 38% of systems ran above their rated daily volume, shortening cartridge life by a median 27%. Systems on a service contract spent 22% more a year but logged 41% fewer days out of specification. Feed water above 20 microsiemens per centimetre, the ASTM D1193 limit for Type I feed, doubled cartridge spend. Douglas Insights uses the 2,480-system ledger to set consumable spend per laboratory and the service attach rate; each 10-point rise in contract coverage adds about 0.2 points a year to base case spend growth.

Methodology and receipts: how do 468,000 laboratories add up to USD 2.92 billion?

The laboratory grade water market model multiplies about 468,000 laboratories buying purified water in 2025 by an average USD 6,240 per laboratory, giving USD 2.92 billion, or USD 2.9 billion at one decimal. Adopters and spend were chosen over units and price because about 53% of value recurs each year as consumables, service and bottles. Laboratory counts come from R&D statistics, hospital and testing lab registers and supplier installed bases; spend comes from list prices, tenders and the 2,480-system ledger. The forecast compounds 3.4% laboratory growth and 2.35% spend growth to about 653,800 laboratories at USD 7,870 each, and USD 5.15 billion, in 2035.

Sources

1. Xylem Inc., U.S. Securities and Exchange Commission EDGAR Xylem completes acquisition of Evoqua (Exhibit 99.1 to Form 8-K) (2023)
2. ASTM International ASTM D1193-06(2018): Standard Specification for Reagent Water (2018)
3. European Medicines Agency Guideline on the quality of water for pharmaceutical use (EMA/CHMP/CVMP/QWP/496873/2018) (2020)
4. National Center for Science and Engineering Statistics, U.S. National Science Foundation U.S. R&D Totaled $937 Billion in 2023; Estimate for 2024 Indicates Further Increase to $993 Billion (NSF 26-314) (2026)